Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

OCL

POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE

Standard Dose
6GM/100ML;75MG/100ML;168MG/100ML;146MG/100ML;1.29GM/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview OCL is listed in Drugs@FDA under application 019284 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE Form and strength SOLUTION;ORAL - 6GM/100ML;75MG/100ML;168MG/100ML;146MG/100ML;1.29GM/100ML Sponsor HOSPIRA Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview OCL is listed in Drugs@FDA under application 019284 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE Form and strength SOLUTION;ORAL - 6GM/100ML;75MG/100ML;168MG/100ML;146MG/100ML;1.29GM/100ML Sponsor HOSPIRA Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.